Commentary
REMDESIVIR: A PRODRUG FOR PATIENTS WITH SEVERE COVID-19
DOI: 10.21276/2395-2466.22.10.0078
Short Communication
EFFECTIVENESS OF ANTINEOPLASTIC DRUG FOR MALIGNANT DISEASES
DOI: 10.21276/2395-2466.22.10.0082
Opinion Article
DAILY DOSAGES OF ACETAMINOPHEN IN ADULTS AND CHILDREN
DOI: 10.21276/2395-2466.22.10.0081